Further analysis revealed that PDE5A-500aa promoted USP14-mediated de-ubiquitination-associated post-translational modification of PIK3IP1 to attenuate PI3K/AKT signaling, thereby inhibiting ESCC proliferation and metastasis. The gene discussed is PIK3IP1; the disease is esophageal squamous cell carcinoma.